Microbiome diagnostics could be employed to improve disease diagnostics, quantify disease risk , predict disease severity and progression , and tailor drug-choice to individual patients.
The following publication by the Knowledge Transfer Network (KTN) “Microbiome Strategic Roadmap” can offer knowledge to the OActive Project community: https://cutt.ly/lkomeY4
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. More Info
Cookies are small text files held on your computer. Some cookies are required to ensure that the site functions correctly, for this reason we may have already set some cookies. They also allow us to give you the best browsing experience possible and help us understand how you use our site. For more information read our Privacy Policy.